Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DISTINCT Trial: inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT: a National, Multicenter, Randomized, Multi-arm, Open-label Trial.

NCT06581965 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06581965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DISTINCT Trial: inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT: a National, Multicenter, Randomized, Multi-arm, Open-label Trial.
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
November 11, 2024
Completion date
February 1, 2031
Enrollment
10,078 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism, venous thromboembolism, venous thromboses